event tracking

Parkinson’s Disease

168 results.

VAI DEFAULT HEADER
July 11, 2016 Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease

Note: To read the commentary published in the Journal of Parkinson's Disease click here.

Investigators will focus on safety for long-term use in non-cancer…

June 13, 2016 Lessons from lactose intolerance: Investigating epigenomic aging

New insights into lactose intolerance may give scientists more than a better understanding of why some people lose the ability to digest…

May 23, 2016 Explaining the epigenome: An interview with Dr. Viviane Labrie (part two)

Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the…

May 16, 2016 Explaining the epigenome: An interview with Dr. Viviane Labrie (part one)

Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the…

April 26, 2016 Founder of movement disorders field to receive Parkinson’s award

 Stanley Fahn, M.D., honored by Van Andel Institute

GRAND RAPIDS, Mich. (April 27, 2016)—In honor of his immeasurable contributions to the study and treatment of movements…

April 3, 2016 Changing the course: Parkinson’s disease research in 2016

By Patrik Brundin, M.D., Ph.D.
Director, Center for Neurodegenerative Science

The time has come to shift the paradigm on Parkinson’s disease.

Never before have…

VAI DEFAULT HEADER
April 3, 2016 Infographic: Seven Parkinson's terms to know

Parkinson’s is a progressive disease caused by the abnormal clumping of a protein in brain cells, some of which produce a chemical called dopamine that…

VAI DEFAULT HEADER
February 21, 2016 Promising respiratory drug focus of new clinical trial for Parkinson’s disease

GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…